Examples of 'nanocarriers' in a sentence
Meaning of "nanocarriers"
Nanocarriers - particles or molecules designed to encapsulate and transport drugs or other substances at the nanoscale level. In English, nanocarriers are commonly used in drug delivery systems
Show more definitions
- plural of nanocarrier
How to use "nanocarriers" in a sentence
Basic
Advanced
nanocarriers
Nanocarriers as an emerging platform for cancer therapy.
Existing and potential drug nanocarriers have been reviewed.
Nanocarriers are nanomaterials used as a mode of transporting another substance.
In embodiments antigens are coadministered with the synthetic nanocarriers.
This allows nanocarriers to accumulate in the tumor.
Coupling antibiotics with nanocarriers.
Synthetic nanocarriers may comprise a plurality of different layers.
An alternative would be to target the drugs to these organs via nanocarriers.
Synthetic nanocarriers can comprise a plurality of different layers.
Surface antigens can be coupled to the synthetic nanocarriers by a variety of methods.
Nanocarriers have several advantages over conventional chemotherapy.
A wide variety of synthetic nanocarriers can be used according to the invention.
In other embodiments antigens are not coadministered with the synthetic nanocarriers.
The nanocarriers are then injected into the blood stream.
In other implementations antigens are not coadministered with the synthetic nanocarriers.
See also
These nanocarriers may be linked if necessary to tumor specific ligands.
Curcumin encapsulation as an anticancer agent and nanocarriers cytotoxicity towards cancer cells were verified.
Synthetic nanocarriers according to the invention comprise one or more surfaces.
One of the most promising alternatives is the development of nanocarriers containing antitumor substances.
Polymeric nanocarriers for specific drug delivery in the cellular environment.
This document teaches the use of lipoaminoglycosides as nanocarriers for nucleic acid delivery.
The size of the nanocarriers depends on the intended particular use.
Adjusting their size and composition modulated the interaction of the nanocarriers with the epithelial tissue.
Synthetic nanocarriers can be solid or hollow and can comprise one or more layers.
This thesis naturally opens the way for the study of biocompatible nanocarriers for drug delivery.
Liposomes were the first nanocarriers approved by regulatory agencies for carrier several chemotherapeutic agents.
In some implementations, synthetic nanocarriers are cubes or cubic.
Some nanocarriers contain nanotube arrays allowing them to contain both hydrophobic and hydrophilic drugs.
In some embodiments, synthetic nanocarriers are cubes or cuboidal.
The nanocarriers can then be combined to form a NC suspension for further testing.
In implementations, synthetic nanocarriers can used as carriers.
In embodiments, antigens are coupled to the synthetic nanocarriers.
One potential problem with nanocarriers is unwanted toxicity from the type of nanomaterial being used.
In certain implementations, antigens are coupled to the synthetic nanocarriers.
In some embodiments, synthetic nanocarriers are ovals or ellipses.
In other implementations, antigens are not coupled to the synthetic nanocarriers.
In some embodiments, synthetic nanocarriers are spheres or spheroids.
In other embodiments, antigens are not coupled to the synthetic nanocarriers.
In some implementations, synthetic nanocarriers are spheres or spheroids.
In embodiments, surface antigens are coupled to a surface of the synthetic nanocarriers.
In some implementations, synthetic nanocarriers are ovals or ellipses.
Superparamagnetic iron oxide nanoparticles ( spions ) have been widely investigated as nanocarriers.
In embodiments, the synthetic nanocarriers do not comprise chitosan.
Nanocarriers include vesicles such as liposomes and micelles, as well as polymeric nanoparticles, etc.
In implementations, inventive synthetic nanocarriers do not comprise chitosan.
The nanocarriers described therein comprise an immune-feature surface and an adjuvant as an immune-stimulatory moiety.
In some embodiments, synthetic nanocarriers do not comprise a polymeric component.
Preferably, " vector " refers to biomolecules, peptides, antibodies, organic compound or nanocarriers.
In some embodiments, the synthetic nanocarriers comprise one or more polymers.
Preferably, " bioactive group " or " vector " refers to biomolecules, organic compounds or nanocarriers.
